Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

DNA methylation gene-based models indicating independent poor outcome in prostate cancer

  • Nataša Vasiljević1,
  • Amar S Ahmad1,
  • Mangesh A Thorat1,
  • Gabrielle Fisher1,
  • Daniel M Berney2,
  • Henrik Møller3,
  • Christopher S Foster4,
  • Jack Cuzick1 and
  • Attila T Lorincz1Email author
BMC Cancer201414:655

https://doi.org/10.1186/1471-2407-14-655

Received: 16 March 2014

Accepted: 30 August 2014

Published: 6 September 2014

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
16 Mar 2014 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
11 Apr 2014 Reviewed Reviewer Report - Joseph Koopmeiners
27 Jul 2014 Author responded Author comments - Attila Lorincz
Resubmission - Version 4
27 Jul 2014 Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
4 Aug 2014 Author responded Author comments - Attila Lorincz
Resubmission - Version 6
4 Aug 2014 Submitted Manuscript version 6
Publishing
30 Aug 2014 Editorially accepted
6 Sep 2014 Article published 10.1186/1471-2407-14-655

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine, Queen Mary University of London
(2)
Molecular Oncology Centre, Barts Cancer Institute, Queen Mary University of London
(3)
King’s College London, Cancer Epidemiology and Population Health
(4)
HCA International Pathology Laboratories

Advertisement